FDA Inspection
Glaxo Operations UK Ltd.Glaxo Operations UK Ltd. – FDA Inspection, Jun 20, 2016
Record Details
This FDA Inspection record concerns Glaxo Operations UK Ltd., with an inspection on June 20, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Glaxo Operations UK Ltd.
- Inspection Date
- June 20, 2016
- Product Type
- Drugs
View Company Profile
ID · 3abe7832-914d-44a8-a193-dc940c743a51
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 984368
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Glaxo Operations UK Ltd.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| May 25, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 4, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 9, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Glaxo Operations UK Ltd.
- FDA Inspection 1061917 - 2017-05-25
- FDA Inspection 886186 - 2014-04-04
- FDA Inspection 746858 - 2011-09-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.